Associated Papers
Convergent and Divergent Mechanisms of Epileptogenesis in mTORopathies.
Nguyen LH et al.
Frontiers in Neuroanatomy, 2021
Pathological mTOR mutations impact cortical development.
Tarkowski B et al.
Human Molecular Genetics, 2019
ULK1 O-GlcNAcylation Is Crucial for Activating VPS34 via ATG14L during Autophagy Initiation.
Pyo KE et al.
Cell Reports, 2018
Evidence Supporting a Lymphatic Endothelium Origin for Angiomyolipoma, a TSC2(-) Tumor Related to Lymphangioleiomyomatosis.
Yue M et al.
The American Journal of Pathology, 2016
Unrestrained mammalian target of rapamycin complexes 1 and 2 increase expression of phosphatase and tensin homolog deleted on chromosome 10 to regulate phosphorylation of Akt kinase.
Das F et al.
The Journal of Biological Chemistry, 2012
Mammalian TOR signaling to the AGC kinases.
Su B et al.
Critical Reviews in Biochemistry and Molecular Biology, 2011
Activating mutations of TOR (target of rapamycin).
Hardt M et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms, 2011
Activating mutations in TOR are in similar structures as oncogenic mutations in PI3KCalpha.
Sturgill TW et al.
Acs Chemical Biology, 2009
Evaluation of mTOR function by a gain-of-function approach.
Ohne Y et al.
Cell Cycle (georgetown, Tex.), 2009
Isolation of hyperactive mutants of mammalian target of rapamycin.
Ohne Y et al.
The Journal of Biological Chemistry, 2008
Select a paper to view details